Baidu
map

肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

Cancer Prev Res ：绿茶儿茶酚不能预防前列腺癌的发生

2015-05-09 范伟译 MedSci原创

绿茶儿茶酚前列腺癌
关注

背景：前临床、流行病学的和先前临床试验数据显示绿茶儿茶酚(GTCs)可能降低前列腺癌(PCa)的风险。方法：针对和茶多酚E®(PolyE)，特有的GTCs混合物，含有400毫克(-)-表没食子儿茶素-3-没食子酸酯(EGCG)，我们对97名高级前列腺上皮内瘤(HGPIN)和/或非典型小腺泡增殖(ASAP)的男性患者进行了一项安慰剂对照、随机的临床试验 。主要研究终点是在两个研究组对累积一年内前列腺


背景：前临床、流行病学的和先前临床试验数据显示绿茶儿茶酚(GTCs)可能降低前列腺癌(PCa)的风险。

方法：针对和茶多酚E®(PolyE)，特有的GTCs混合物，含有400毫克(-)-表没食子儿茶素-3-没食子酸酯(EGCG)，我们对97名高级前列腺上皮内瘤(HGPIN)和/或非典型小腺泡增殖(ASAP)的男性患者进行了一项安慰剂对照、随机的临床试验 。主要研究终点是在两个研究组对累积一年内前列腺癌PCa发病率进行比较。

结果：在大量的PCa病例中没有观察到差异：5/49(PolyE) vs 9/48(安慰剂)，P = 0.25。次要终点是高级前列腺上皮内瘤没有非典型小腺泡增殖的男性在基线比较累积PCa加ASAP的发病率，显示在这个复合终点有降低：3/26(PolyE) vs 10/25(安慰剂)，P < 0.024。这一发现是由Poly E组(0/26)相比安慰剂组(5/25)诊断为ASAP的减少证实的。降低的血清前列腺特异抗原(PSA)在Poly E组[-0.87 ng / ml(95% 置信区间 CI：-1.66，-0.09)] 也观察到。相关研究的不良反应在两个研究组间没有显著差异。

结论：每日摄取标准化，无咖啡因的儿茶酚混合物含有400毫克EGCG ，1年内累积血浆中，耐受性较好，但不会减少基线HGPIN或ASAP男性前列腺癌的可能性。

原始出处：
Kumar NB1, Pow-Sang J2, Egan KM3, Spiess PE4, Dickinson S5, Salup R6, Helal M7, McLarty JW8, Williams CR9, Schreiber F Medical Oncology10, Parnes HL11, Sebti S12, Kazi A13, Kang L14, Quinn GP15, Smith T16, Yue B17, Diaz K16, Chornokur G18, Crocker T19, Schell MJ20.Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.Cancer Prev Res (Phila). 2015 Apr 14. pii: canprevres.0324.2014. 

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=24789, encodeId=9c6f24e894b, content=这个矛盾的问题，大家可以做做meta分析吧？整合所有数据探讨是否还是不是能减少风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 08:10:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23463, encodeId=ddd623463b1, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed May 13 21:26:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402282, encodeId=2469140228207, content=<a href='/topic/show?id=862e8e196a1' target=_blank style='color:#2F92EE;'>#茶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87196, encryptionId=862e8e196a1, topicName=茶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eTyQ1TyLVfyaGrflWSd1Jw4u1F68ibicmN32DE38FjEW3zTIKeFeaMUAQsjyqaL4QZ3lRibFIzziacMz9niceznOTTw/132, createdBy=03082405249, createdName=hbwxf, createdTime=Mon May 11 13:34:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23102, encodeId=17ab2310213, content=对其它肿瘤呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun May 10 16:08:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23082, encodeId=af342308289, content=不过绿茶还是不错的！, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23083, encodeId=c441230838d, content=看过了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23073, encodeId=ed61230e375, content=看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Sun May 10 01:10:00 CST 2015, time=2015-05-10, status=1, ipAttribution=)]
    2015-05-25 jasonuclear

    这个矛盾的问题，大家可以做做meta分析吧？整合所有数据探讨是否还是不是能减少风险

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=24789, encodeId=9c6f24e894b, content=这个矛盾的问题，大家可以做做meta分析吧？整合所有数据探讨是否还是不是能减少风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 08:10:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23463, encodeId=ddd623463b1, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed May 13 21:26:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402282, encodeId=2469140228207, content=<a href='/topic/show?id=862e8e196a1' target=_blank style='color:#2F92EE;'>#茶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87196, encryptionId=862e8e196a1, topicName=茶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eTyQ1TyLVfyaGrflWSd1Jw4u1F68ibicmN32DE38FjEW3zTIKeFeaMUAQsjyqaL4QZ3lRibFIzziacMz9niceznOTTw/132, createdBy=03082405249, createdName=hbwxf, createdTime=Mon May 11 13:34:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23102, encodeId=17ab2310213, content=对其它肿瘤呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun May 10 16:08:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23082, encodeId=af342308289, content=不过绿茶还是不错的！, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23083, encodeId=c441230838d, content=看过了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23073, encodeId=ed61230e375, content=看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Sun May 10 01:10:00 CST 2015, time=2015-05-10, status=1, ipAttribution=)]
    2015-05-13 huaxipanxing

    看看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=24789, encodeId=9c6f24e894b, content=这个矛盾的问题，大家可以做做meta分析吧？整合所有数据探讨是否还是不是能减少风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 08:10:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23463, encodeId=ddd623463b1, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed May 13 21:26:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402282, encodeId=2469140228207, content=<a href='/topic/show?id=862e8e196a1' target=_blank style='color:#2F92EE;'>#茶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87196, encryptionId=862e8e196a1, topicName=茶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eTyQ1TyLVfyaGrflWSd1Jw4u1F68ibicmN32DE38FjEW3zTIKeFeaMUAQsjyqaL4QZ3lRibFIzziacMz9niceznOTTw/132, createdBy=03082405249, createdName=hbwxf, createdTime=Mon May 11 13:34:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23102, encodeId=17ab2310213, content=对其它肿瘤呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun May 10 16:08:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23082, encodeId=af342308289, content=不过绿茶还是不错的！, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23083, encodeId=c441230838d, content=看过了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23073, encodeId=ed61230e375, content=看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Sun May 10 01:10:00 CST 2015, time=2015-05-10, status=1, ipAttribution=)]
    2015-05-11 hbwxf

    #茶#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=24789, encodeId=9c6f24e894b, content=这个矛盾的问题，大家可以做做meta分析吧？整合所有数据探讨是否还是不是能减少风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 08:10:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23463, encodeId=ddd623463b1, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed May 13 21:26:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402282, encodeId=2469140228207, content=<a href='/topic/show?id=862e8e196a1' target=_blank style='color:#2F92EE;'>#茶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87196, encryptionId=862e8e196a1, topicName=茶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eTyQ1TyLVfyaGrflWSd1Jw4u1F68ibicmN32DE38FjEW3zTIKeFeaMUAQsjyqaL4QZ3lRibFIzziacMz9niceznOTTw/132, createdBy=03082405249, createdName=hbwxf, createdTime=Mon May 11 13:34:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23102, encodeId=17ab2310213, content=对其它肿瘤呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun May 10 16:08:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23082, encodeId=af342308289, content=不过绿茶还是不错的！, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23083, encodeId=c441230838d, content=看过了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23073, encodeId=ed61230e375, content=看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Sun May 10 01:10:00 CST 2015, time=2015-05-10, status=1, ipAttribution=)]
    2015-05-10 223.104.5.**

    对其它肿瘤呢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=24789, encodeId=9c6f24e894b, content=这个矛盾的问题，大家可以做做meta分析吧？整合所有数据探讨是否还是不是能减少风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 08:10:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23463, encodeId=ddd623463b1, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed May 13 21:26:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402282, encodeId=2469140228207, content=<a href='/topic/show?id=862e8e196a1' target=_blank style='color:#2F92EE;'>#茶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87196, encryptionId=862e8e196a1, topicName=茶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eTyQ1TyLVfyaGrflWSd1Jw4u1F68ibicmN32DE38FjEW3zTIKeFeaMUAQsjyqaL4QZ3lRibFIzziacMz9niceznOTTw/132, createdBy=03082405249, createdName=hbwxf, createdTime=Mon May 11 13:34:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23102, encodeId=17ab2310213, content=对其它肿瘤呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun May 10 16:08:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23082, encodeId=af342308289, content=不过绿茶还是不错的！, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23083, encodeId=c441230838d, content=看过了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23073, encodeId=ed61230e375, content=看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Sun May 10 01:10:00 CST 2015, time=2015-05-10, status=1, ipAttribution=)]
    2015-05-10 yydlt

    不过绿茶还是不错的！

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=24789, encodeId=9c6f24e894b, content=这个矛盾的问题，大家可以做做meta分析吧？整合所有数据探讨是否还是不是能减少风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 08:10:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23463, encodeId=ddd623463b1, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed May 13 21:26:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402282, encodeId=2469140228207, content=<a href='/topic/show?id=862e8e196a1' target=_blank style='color:#2F92EE;'>#茶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87196, encryptionId=862e8e196a1, topicName=茶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eTyQ1TyLVfyaGrflWSd1Jw4u1F68ibicmN32DE38FjEW3zTIKeFeaMUAQsjyqaL4QZ3lRibFIzziacMz9niceznOTTw/132, createdBy=03082405249, createdName=hbwxf, createdTime=Mon May 11 13:34:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23102, encodeId=17ab2310213, content=对其它肿瘤呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun May 10 16:08:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23082, encodeId=af342308289, content=不过绿茶还是不错的！, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23083, encodeId=c441230838d, content=看过了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23073, encodeId=ed61230e375, content=看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Sun May 10 01:10:00 CST 2015, time=2015-05-10, status=1, ipAttribution=)]
    2015-05-10 yydlt

    看过了！

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=24789, encodeId=9c6f24e894b, content=这个矛盾的问题，大家可以做做meta分析吧？整合所有数据探讨是否还是不是能减少风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon May 25 08:10:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23463, encodeId=ddd623463b1, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed May 13 21:26:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402282, encodeId=2469140228207, content=<a href='/topic/show?id=862e8e196a1' target=_blank style='color:#2F92EE;'>#茶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87196, encryptionId=862e8e196a1, topicName=茶)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eTyQ1TyLVfyaGrflWSd1Jw4u1F68ibicmN32DE38FjEW3zTIKeFeaMUAQsjyqaL4QZ3lRibFIzziacMz9niceznOTTw/132, createdBy=03082405249, createdName=hbwxf, createdTime=Mon May 11 13:34:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23102, encodeId=17ab2310213, content=对其它肿瘤呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Sun May 10 16:08:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23082, encodeId=af342308289, content=不过绿茶还是不错的！, beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23083, encodeId=c441230838d, content=看过了！, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sun May 10 10:52:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23073, encodeId=ed61230e375, content=看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Sun May 10 01:10:00 CST 2015, time=2015-05-10, status=1, ipAttribution=)]
    2015-05-10 zhouanxiu

    看过了

    0

相关资讯

Psychopharmacology ：新研究表明绿茶可增强工作记忆

如果说绿茶是一位名人，那么它已经接近了头号大腕的宝座。其活性成分已经被证明对健康有多种益处，包括减轻体重、减少焦虑情绪以及抑制癌细胞的增长。现在一项新的研究表明，它的益处还包括“增强记忆”。 瑞士巴塞尔大学（University of Basel）的研究人员进行了一项简单的实验，在实验中，他们为受试者准备了两种饮料，其中一种饮料中含有27.5克绿茶提取物，还有一种是绿茶味的乳清蛋白饮料，研究人员随

Nature Nanotechnology：绿茶不仅养生，将来也可用于治癌

新加坡科学家最近发现绿茶中的一种有效成分能够作为潜在的纳米载药系统用于输送蛋白药物以治疗癌症。在动物试验中，研究人员利用这种名为没食子酸（EGCG）的抗氧化剂来装载罗氏和基因泰克的抗乳腺癌药物Herceptin，相比于对照组，载药系统组疗效超出了两倍之多。同时，通过载药系统包载后，药物在肝脏和肾脏的积累降低了70%左右，在肺部的积累降低了40%。这一研究已经被发表在著名期刊 Nature Na

绿茶或可杀死口腔内癌细胞

据英国《每日邮报》2月4日报道，经研究发现，绿茶中所含的混合物可杀死口腔癌细胞，而健康细胞不受影响。人们都知道喝绿茶可以抵抗疾病。科学家们正在研究研究其原因，确认破坏癌细胞的物质，从而找到治疗口腔癌的以及其他疾病的办法。 美国宾夕法尼亚大学的科学家们对绿茶混合物如何瞄准病变细胞进行了详细探索。早期研究表明绿茶中的混合物表没食子儿茶素没食子酸酯(简称EGCG)可杀死口腔癌细胞，而健康细胞不受影响。

Nat Nanotechnol：绿茶主要成分或可用作抗癌蛋白载体

绿茶中的一种主要成分能够作为抗癌蛋白载体，用来合成一种稳定、有效的治疗用纳米复合物。在线发表于《自然-纳米技术》上的这项发现或有助于建立更好的药物投递系统。 一些癌症治疗方法的效果依赖于药剂中的治疗成分和将药物投递至肿瘤位置的载体。设计药物载体时，有几个因素必须考虑：首先，其必须具有特定性，这样才能针对肿瘤而不伤及其他组织；其次，药物与载体的配比也很重要，因为如果身体无法代谢载体的话

PLOS ONE：绿茶有助预防老年痴呆症

日本一个研究小组最新研究发现，绿茶具有预防老年痴呆症的作用，习惯每天喝绿茶的人，患病率大约只有不喝绿茶人的三分之一。 从2007年到2013年，日本金泽大学研究人员以石川县的490名60岁以上的居民为对象，调查了老年痴呆症的发病率。结果发现，在完全没有饮用绿茶习惯的138人中，有43人患上老年痴呆症或者轻度认知障碍；而每天饮用绿茶的157人中，只有18人患病。另外还发现，隔三差五喝绿茶的人患病风险

Mol Nutr Food Res：绿茶可杀死口腔癌细胞

Mol Nutr Food Res：绿茶可杀死口腔癌细胞关键词：表没食子儿茶素没食子酸酯 口腔癌  促氧化作用 绿茶据估计，美国2014年大约有42440个口腔癌新发病例和8390个因口腔癌而死亡的病例。吸烟室主要的致病因素，它能诱导基因突变从而提高额口腔癌发病的风险。基于此，采取膳食措施以预防口腔癌的发生将会是一个很有前景的方法。表没食子儿茶素没食子酸酯（EGCG）是绿茶中最丰富的多酚

Baidu
map
Baidu
map
Baidu
map